Company Toleranzia AB

Equities

TOL

SE0007438577

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 09:30:00 28/06/2024 pm IST 5-day change 1st Jan Change
0.628 SEK -1.57% Intraday chart for Toleranzia AB -1.88% +46.73%

Business Summary

Toleranzia AB is a Sweden-based company engaged in the development of a platform technology for treatment of autoimmune diseases. The Company's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company’s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.

Number of employees: 10

Managers

Managers TitleAgeSince
Chief Executive Officer 57 -
Director of Finance/CFO 72 30/23/30
Chief Tech/Sci/R&D Officer 65 17/18/17
Corporate Officer/Principal 72 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 60 01/20/01
Director/Board Member 64 01/21/01
Director/Board Member 63 01/18/01
Director/Board Member 74 01/18/01
Chairman 61 01/20/01
Director/Board Member 63 01/17/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 197,070,875 159,591,773 ( 80.98 %) 0 80.98 %

Company contact information

Toleranzia AB

Arvid Wallgrens backe 20 8th Floor

413 46, Gothenburg

+46 7 63 19 98 98

http://www.toleranzia.se
address Toleranzia AB(TOL)
  1. Stock Market
  2. Equities
  3. TOL Stock
  4. Company Toleranzia AB